Chantix Tablet, Film Coated
Product Images NDC 0069-0469
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 0069-0469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Chantix 02)
Figure 2 (Chantix 03)
Figure 3 (Chantix 04)
Logo (Chantix 05)
Logo (Chantix 06)
Principal Display Panel (0.5 / 1 mg Tablet Starting Pack Carton)
This appears to be the packaging and instructions for a medication called Chantix (varenicline), which is used to help people quit smoking. It includes a Starting Month box with a green blister card to be used for the first four weeks of treatment and a Continuing Weeks box for the remainder of the 12-week program. The text includes dosage information and a drug identification number, but there are also some errors and unclear characters, making it difficult to fully understand.*
Principal Display Panel (0.5 mg / 1 mg Tablet Starting Pack)
Chantix is a prescription medication used to help individuals quit smoking. The Starting Pack includes a green blister card with 11 tablets of 0.5 mg and three blister cards with 42 1 mg tablets intended for use during the continuing weeks. The medication guide enclosed in the package should always be consulted. Each tablet contains 0.85 mg varenicline tartrate equivalent to 100.5 mg varenicline free base. The medication should be stored at room temperature (15-30°C).*
Principal Display Panel (0.5 mg Tablet Bottle Label)
This is a description of a medication called Chantix, also known as varenicline, which contains 0.85 mg of varenicline tartrate or 0.5 mg of varenicline as its active ingredient per tablet. The medication is meant to be stored at a controlled room temperature not exceeding 30°C or 86°F for USP. Excursions are permitted at 15-30°C (59-86°F). Tamper-resistant and child-resistant containers must be used for dispensing purposes. The accompanying prescribing information should be consulted for dosage and usage instructions. The medication is distributed by Pfizer Labs, a division of Pfizer Inc, located in NY 10017, and is made in Ireland with the item number of N3 0069046856 3.*
Principal Display Panel (1 mg Tablet Bottle Label)
This is a prescription medication called Chantix, containing varenicline as a tartrate salt equivalent to free base. It is dispensed in a container that is child-resistant and tight. The medication should be stored at room temperature with excursions permitted to a certain range. The recommended dosage and use of the medication can be found in the prescribing information that comes with it. Distributed by Pfizer Labs, a division of Pfizer Inc. It was made in Ireland and comes in a 56 tablet package with a specific NDC and GTIN number, as well as a LOT and EXP number.*
Principal Display Panel (1 mg x 56 Tablet Continuing Pack)
Principal Display Panel (1 mg x 56 Tablet Continuing Month Box)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.